Giotrif
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Giotrif, covering 2016-10-31 to 2025-03-31. Get the full timeline:
Most recent: EMA Authorised: Giotrif (afatinib) — Boehringer Ingelheim International GmbH